iStar Medical SA
Industry
- Biotechnology
- Medical Devices
- Surgical Equipment & Devices
- Minimally or Less Invasive
- Implantable Devices
- Biomaterials
- Surgical Equipment & Devices
Latest on iStar Medical SA
This month, AbbVie gave iStar Medical an upfront cash payment to continue the development of its glaucoma devices, with the deal also granting AbbVie the option to purchase iSTAR outright for near
July was yet another bumper month for pharma, which saw France-based Sanofi ink a $2bn deal with Skyhawk Therapeutics to develop small molecule drugs for oncology and immunology. (Also see " Sanof
In a deal described by the two companies as a “strategic alliance,” AbbVie has paid iStar Medical SA $60m to continue the development and commercialization of iSTAR’s MINIject glaucoma device. The
iSTAR has obtained a CE mark for MINIject, an implantable device used to reduce intraocular pressure in patients with glaucoma. The granting of a CE mark makes MINIject the only commercially availabl